24. The prognostic value of mitotic rate in recurrent melanoma

Rajmohan Murali; Marc Moncrieff; Jonathan Hong; Caroline Cooper; Meena Shingde; David Samuel; John F. Thompson; Richard A Scolyer

doi:10.1016/s0031-3025(16)33312-8

Related publications

Article2010

The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma

Rajmohan Murali, Marc Moncrieff, Jonathan Hong, Caroline Cooper, Meena Shingde, David Samuel, John F. Thompson, Richard A Scolyer

Article2019

The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study

Norbertus A. Ipenburg, Serigne Lo, Ricardo E. Vilain, Lodewijka H. J. Holtkamp, James S. Wilmott, Omgo E. Nieweg, John F. Thompson, Richard A Scolyer

Letter2006

The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma

Richard A Scolyer, John F. Thompson, Helen M. Shaw, Richard A Scolyer, John F. Thompson, John F. Thompson, Richard A Scolyer, John F. Thompson

Article2020

Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system

Mohammed Kashani–Sabet, James R. Miller, Serigne Lo, Mehdi Nosrati, Jonathan R. Stretch, Kerwin F. Shannon, Andrew J. Spillane, Robyn P.M. Saw, James E. Cleaver, Kevin B. Kim, Stanley P. L. Leong, John F. Thompson, Richard A Scolyer

Article2010

Cancer–testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate

Suzanne Svobodová, Judy Browning, Duncan MacGregor, Gabriele Pollara, Richard A Scolyer, Rajmohan Murali, John F. Thompson, Siddhartha Deb, Arun Azad, Ian D. Davis, Jonathan Cebon